BioNTech
BNTX · NASDAQ
Bulios Fair Price
$144
47.5% upside
Trenutna cena
$97.64
Po podatkih Bulios Fair Price je delnica BNTX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
BioNTech SE is a German biotechnology company focused on the research and development of innovative drugs and therapeutic approaches. The company is well-known for its groundbreaking research and development of mRNA (messenger RNA) technology, which serves as the basis for drug and vaccine development. BioNTech collaborates with pharmaceutical and research partners worldwide and focuses on addressing serious diseases such as cancer, infectious diseases, and others. It gained significant recognition through its collaboration with Pfizer on the development and distribution of the COVID-19 vaccine, which became the first mRNA vaccine approved for emergency use. BioNTech SE adheres to high standards of scientific research and innovation and emphasizes the potential to change the way diseases are treated and prevented. Investing in BioNTech SE (BNTX) shares may be an interesting choice for investors who follow the biotechnology sector and seek investment opportunities in an innovative company with promising medical technologies.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Ugur Sahin
Employees
7,807
Headquarters
Mainz
Prihajajoči dogodki
Earnings
Upcoming earnings report